SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-013430
Filing Date
2023-09-19
Accepted
2023-09-19 17:34:00
Documents
2
Period of Report
2023-09-15

Document Format Files

Seq Description Document Type Size
1 form4-09192023_090952.html 4  
1 form4-09192023_090952.xml 4 3142
2 ex24-09192023_090952.htm EX-24 7286
  Complete submission text file 0001415889-23-013430.txt   11954
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Issuer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
PASQUALONE FRANK (Reporting) CIK: 0001597334 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38286 | Film No.: 231264819